These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 4441141

  • 1. [Mechanism of action and cytotoxic, biochemical and histochemical effects of antibodies and complement on neoplastic cells and experimental malignant neoplasms].
    Valguarnera G.
    Ann Sclavo; 1974; 16(4):367-85. PubMed ID: 4441141
    [No Abstract] [Full Text] [Related]

  • 2. [Anticomplement activity of the serum, ascitic fluid and tumor fluid of animals with transplantable experimental neoplasms. Cytotoxic activity of the antibodies].
    Valguarnera G.
    Boll Soc Ital Biol Sper; 1974 Aug 30; 50(13):1013-6. PubMed ID: 4463978
    [No Abstract] [Full Text] [Related]

  • 3. Natural antibodies in normal human sera againist the Ehrlich mouse ascites tumour identified with the aid of complement components, utilizing classical reagents.
    Oravec C, Cambelová J.
    Neoplasma; 1971 Aug 30; 18(2):141-59. PubMed ID: 5577313
    [No Abstract] [Full Text] [Related]

  • 4. Group-specific antigens of ascites rat tumours induced by B77 virus.
    Thurzo V, Lizonová A, Simkovicová M.
    Neoplasma; 1971 Aug 30; 18(6):551-4. PubMed ID: 4334383
    [No Abstract] [Full Text] [Related]

  • 5. Participation of tumor killing factor in the antitumor effect of Sarcophaga lectin.
    Itoh A, Ohsawa F, Ohkuma Y, Natori S.
    FEBS Lett; 1986 May 26; 201(1):37-40. PubMed ID: 3709806
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Cells of various types activated in vitro by phytohemagglutinin. Target cell lysis].
    Roveta G, Pagani G.
    Boll Soc Ital Biol Sper; 1973 Apr 15; 49(7):357-61. PubMed ID: 4361896
    [No Abstract] [Full Text] [Related]

  • 11. Immunological studies on Yoshida sarcoma cells. I. The effect of heterologous anti-Yoshida sarcoma cell antibodies on the lysosomal acid DNase of sarcoma cells.
    Kuroyanagi T, Sugiyama H.
    Jpn J Exp Med; 1970 Jun 15; 40(3):183-90. PubMed ID: 5312120
    [No Abstract] [Full Text] [Related]

  • 12. Host resistance against tumor and its synergic effect with cancer chemotherapy.
    Sato R.
    Gan; 1967 Jun 15; 58(3):211-20. PubMed ID: 6081225
    [No Abstract] [Full Text] [Related]

  • 13. Studies on inhibitory effect of homologous spleen cells on Ehrlich ascites tumor and Yoshida sarcoma.
    Soeda M.
    Nihon Igaku Hoshasen Gakkai Zasshi; 1967 Feb 15; 26(11):1471-82. PubMed ID: 5231926
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Reticulo-endothelial reactions in implanted tumors, especially the occurrence of Langhans' giant cells].
    Weissberg M.
    Osterr Z Erforsch Bekampf Krebskr; 1971 Feb 15; 26(2):92-106. PubMed ID: 5171285
    [No Abstract] [Full Text] [Related]

  • 17. [Acid phosphatase activity and phagocytic capabilities of reticuloendothelial system cells of mice with experimental tumors].
    Durnova GN.
    Biull Eksp Biol Med; 1968 Apr 15; 65(4):85-7. PubMed ID: 5758481
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Generation of non-complement-fixing, blocking factors by lysosomal extract treatment of cytotoxic anti-tumor antibodies.
    Dauphinee MJ, Talal N, Witz IP.
    J Immunol; 1974 Sep 15; 113(3):948-53. PubMed ID: 4413555
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.